Heidelberg
Germany
20
2025-11-06
The entities that hold a legal rights for patent applications filed by inventor Boutros Michael:
Michael Boutros from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#2 | 2023-07-20INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST T-CELL MEDIATED CYTOTOXICITY, AND USES THEREOF
#3 | 2021-02-11INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#4 | 2020-05-28MODULATORS OF TUMOR IMMUNE RESISTANCE FOR THE TREATMENT OF CANCER
#5 | 2020-01-23OR10H1 ANTIGEN BINDING PROTEINS AND USES THEREOF
#6 | 2020-01-02Cytotoxic T cell response modifiers
#7 | 2019-08-29IMMUNE MODULATORS FOR REDUCING IMMUNE-RESISTANCE IN MELANOMA AND OTHER PROLIFERATIVE DISEASES
#8 | 2019-02-21MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES
#9 | 2018-11-22CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS
#10 | 2018-10-18CYTOTOXIC T CELL RESPONSE MODIFIERS
#11 | 2016-12-08Chromene derivatives and their analogs as Wnt pathway antagonists
#12 | 2016-11-03Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
#13 | 2016-07-14Cytotoxic T cell response modifiers
#14 | 2014-08-14Gpr177 as target and marker in tumors
#15 | 2014-02-13Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
#16 | 2013-11-14Chromene derivatives and their analoga as Wnt pathway antagonists
#17 | 2013-11-07CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS
#18 | 2013-08-01NOVEL MODULATORS OF TRAIL SIGNALLING
#19 | 2012-06-21Tricyclic pyrimidine derivatives as wnt antagonists
#20 | 2009-07-23IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING
364807 ⎘